Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 3, 2014, Pages 1447-1451

  Ozbek, Emin ^a   Otunctemur, Alper ^a   Dursun, Murat ^a   Koklu, Ismail ^a   Sahin, Suleyman ^a   Besiroglu, Huseyin ^a   Erkoc, Mustafa ^a   Danis, Eyyup ^a   Bozkurt, Muammer ^a  

^a OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Bladder cancer; Diabetes mellitus; Grade; Metabolic syndrome; Stage; Urothelial carcinom

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; BLADDER; BLADDER TUMOR; BLOOD; BODY MASS; CANCER GRADING; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; UROTHELIUM; WAIST CIRCUMFERENCE;

BODY MASS INDEX; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASM GRADING; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM; WAIST CIRCUMFERENCE;

EID: 84896894619     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.3.1447     Document Type: Article

References (37)

1. Batty GD, Shipley MJ, Jarrett RJ, et al (2005). Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes, 29, 1267-74.
2. Borena W, Strohmaier S, Lukanova A, et al (2011). Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer, 43, 1-25.
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38.
4. Chen HS, Su LT, Lin SZ, et al (2012). Increased risk of urinary tract calculi among patients with diabetes mellitus-a population-based cohort study. Urology, 79, 86-92.
5. Chow WH, Lindblad P, Gridley G, et al (1997). Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst, 89, 1453-7.
6. Cowey S, Hardy RW (2006). The metabolic syndrome: A highrisk state for cancer? Am J Pathol, 169, 1505-22.
7. Currie CJ, Poole CD, Jenkins-Jones S, et al (2012). Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival. Diabetes Care, 35, 299-304.
8. Dunn SE, Kari FW, French J, et al (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res, 57, 4667-72.
9. Eckel RH (2007). Treating dyslipidemia of the metabolic syndrome: where's the evidence? Nat Clin Pract Endocrinol Metab, 3, 437.
10. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Association between smoking and risk of bladder cancer among men and women. JAMA, 306, 737-45.
11. Funfstuck R, Nicolle LE, Hanefeld M, Naber KG (2012). Urinary tract infection in patients with diabetes mellitus. Clin Nephrol, 77, 40-8.
12. Gorbachinsky I, Akpinar H, Assimos DG (2010). Metabolic syndrome and urologic diseases. Rev Urol, 12, 157-80.
13. Grove JS, Nomura A, Severson RK, Stemmermann GN (1991). The association of blood Pressure with cancer incidence in a prospective Study. Am J Epidemiol, 134, 942-7.
14. Haggstrom C, Stocks T, Rapp K, et al (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). International journal of cancer. Journal international du cancer, 128, 1890-8.
15. Hiatt RA, Fireman BH (1986). Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis, 39, 861-70.
16. Hole DJ, Hawthorne VM, Isles CG, et al (1993). Incidence of and mortality from cancer in hypertensive patients. BMJ, 306, 609-11
17. Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS (2007). Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer, 120, 140-6.
18. Hu J, La Vecchia C, de Groh M, et al (2012). Dietary cholesterol intake and cancer. Ann Oncol, 23, 491-500.
19. Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12.
20. Jee SH, Yun JE, Park EJ, et al (2008). Body mass index and cancer risk in Korean men and women. Int J Cancer, 123, 1892-6.
21. Jee SH, Ohrr H, Sull JW, et al (2005). Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 293, 194-202.
22. Koebnick C, Michaud D, Moore SC, et al (2008). Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 17, 1214-21.
23. Larsson SC, Andersson SO, Johansson JE, Wolk A (2008). Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer, 44, 2655-60.
24. Lee MY, Lin KD, Hsiao PJ, Shin SJ (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9.
25. Li N, Yang L, Zhang Y, et al (2011). Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis, 204, 217-23.
26. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K (2012). The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer, 118, 1353-61.
27. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol, 25, 285-95.
28. Qin Q, Xu X, Wang X, et al (2013). Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev, 14, 3117-21.
29. Reeves GK, Pirie K, Beral V, et al (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335, 1134.
30. Rosengren A, Himmelmann A, Wilhelmsen L, Branehog I, Wedel H (1998). Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens, 16, 933-40.
31. Samanic C, Gridley G, Chow WH, et al (2004). Obesity and cancer risk among white and black United States veterans. Cancer Causes Control, 15, 35-43.
32. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006). Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control, 17, 901-9.
33. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA: A Cancer J Clin, 62, 10-29.
34. Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H (2009). Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med, 6, 1000201.
35. Stumpe KO (2002). Hypertension and the risk of cancer: is there new evidence? J Hypertens, 20, 565-7.
36. Yang XQ, Xu C, Sun Y, Han RF (2013). Diabetes mellitus increases the risk of bladder cancer: an updated metaanalysis. Asian Pac J Cancer Prev, 14, 2583-9.
37. Zhao H, Grossman HB, Spitz MR, et al (2003). Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol, 169, 714-7.